Repurchase of convertible notes
Camanio Care AB (publ) has today repurchased the remaining, outstanding convertible notes held by the European Select Growth Opportunities Fund (the “Investor”)
Camanio Care AB (publ) has today repurchased the remaining, outstanding convertible notes held by the European Select Growth Opportunities Fund (the “Investor”), upon mutual consent, at a price equal to their par value, i.e. SEK 2m in aggregate. Both parties agree that the convertible model is for the time being not a perfect financial instrument for Camanio and such repurchase will reduce potential dilution. The Investor is a fund investing around the world in technology and healthcare companies presenting a strong growth potential.
The financing relates to an issuance agreement entered into by Camanio Care and the Investor signed on the evening of Tuesday, 5thDecember 2017. The placement of the first Tranche of 4 million SEK is the first transaction launched under the Agreement. The financing solution and overall framework agreement however remains in place, if it in the future other situations should arise where this instrument would be more suitable.
For terms and conditions of the Notes, please visit Camanio Care’s website:
For further information, please contact:
Catharina Borgenstierna, CEO
Telephone: 0733-93 00 07
About Camanio Care
Camanio Care is a care tech company that develops innovative solutions for an excellent care at home with the individual in focus. Camanio Care offers digital service platforms for digital care, robotics, assistive devices and gamification, with products such as VITAL, BikeAround ™, Bestic® and Giraff ™. Through three focus areas; Activation, Mealtime and Digital care, Camanio Care wishes to support people's basic needs and increase accessibility and quality within health care. Camanio Care AB has its headquarters in Stockholm, a US subsidiary, Camanio Care Inc., as well as distributors in Asia, the Middle East, Hong Kong, Australia and in ten European countries.
Subscribe to our newsletter and/or read more about us, Camanio Care at: www.camanio.com.
This information is information that Camanio Care is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on July 25, 2018.